Epidemiologic characteristics and differential management strategies of seven case series with COVID-19 outbreaks caused by asymptomatic carriers from June 2020 to May 2021 in China.

Cheng Liu, Hongbing Xiang, Anne Manyande, Weiguo Xu, Li Fan, Yunhua Zhang, Boqi Xiang

Abstract read

In one paragraph

Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Characteristics and management of SARS-CoV-2 delta variant-induced COVID-19 infections from May to October 2021 in China: post-vaccination infection cases.American journal of translational research · 2022
Review
Dynamic characteristics of COVID-19 infection in Chinese children.American journal of translational research · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cheng LiuDepartment of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, P. R. China.

Hongbing XiangDepartment of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, P. R. China.

Anne ManyandeSchool of Human and Social Sciences, University of West London London, United Kingdom.

Weiguo XuDepartment of Orthopedics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, P. R. China.

Li FanDepartment of Orthopedics, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, P. R. China.

Yunhua ZhangHubei Provincial Hospital of Traditional Chinese Medicine Wuhan 430061, P. R. China.

Boqi XiangSchool of Public Health, Rutgers University New Brunswick, New Jersey 08854, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the COVID-19 epidemic quickly under control in China in the early stage of 2020, global cooperation/communications may pose great challenges to epidemic control and prevention in the country. Large-scale spread by asymptomatic carriers was a concern. We obtained data on new cluster outbreak regions with COVID-19 caused by asymptomatic carriers from June 2020 to May 2021 in China, and reported the epidemiological characteristics, the possible routes of viral transmission and infection, and different control strategies. These results show the importance of regular screening for high-risk populations and differential management strategies for epidemic control, which provide an objective basis for suppressing the spread of the SARS-CoV-2 virus. These experiences can be used as a reference to minimize the subsequent spread of virus mutants in various places.

Indexed as

asymptomatic carrierCOVID-19 diseasescientific protective strategysevere acute respiratory syndrome coronavirus 2

Identifiers

PMID35559380

PMCPMC9091077

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.